BioGaia has patented a method to produce therapeutic microvesicles from probiotic bacteria for treating various conditions. The patent also covers isolated bacterial strains Bifidobacterium longum DSM 32947 and DSM 32948 in dried or lyophilized form. GlobalData’s report on BioGaia gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights BioGaia AB - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on BioGaia, Lactobacillus probiotics was a key innovation area identified from patents. BioGaia's grant share as of January 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

Therapeutic microvesicles from probiotic bacteria

Source: United States Patent and Trademark Office (USPTO). Credit: BioGaia AB

A recently granted patent (Publication Number: US11857582B2) discloses an isolated bacterial strain, specifically Bifidobacterium longum DSM 32947 or Bifidobacterium longum DSM 32948, in a dried or lyophilized form. The patent also covers a composition containing these bacterial strains, capable of inducing the production of therapeutic microvesicles by other bacteria. Additionally, the composition includes specific drying methods such as spray-drying, spray-freeze drying, or vacuum-drying for optimal preservation and efficacy.

Furthermore, the patent extends to probiotic compositions comprising the isolated bacterial strains mentioned above along with Lactobacillus reuteri strains like L. reuteri DSM 17938 and L. reuteri DSM 32846, either individually or in combination. The probiotic compositions aim to provide a synergistic effect by combining these specific bacterial strains, offering potential health benefits to consumers. The patent highlights the importance of specific bacterial strains and their formulations in developing effective probiotic products with enhanced therapeutic properties.

To know more about GlobalData’s detailed insights on BioGaia, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies